In last Sunday’s CBS 60 Minute interview, Fed. Reserve Chair Jerome Powell expressed optimism that the vaccination programs will spur growth in the U.S. economy. Mr. Powell made the comment as a reflection on the past week’s U.S. stock market trading, which yielded record high indices. However, things took a different turn on Tuesday, after U.S. federal health officials issued a “pause” order in the administration of Johnson & Johnson’s COVID-19 vaccine.

The order came amidst rising concerns on cases of rare blood clots occuring in a number of individuals who received a JNJ vaccination shot. Dr. Anthony Fauci said in a press briefing that the review of J&J’s vaccine by medical experts and healthcare authorities, will take days up to weeks to resolve.

As official health reports have it, more than 6.8 million of J&J’s single-dose shots have already been administered across the U.S. Six cases of severe blood clots have been reported as after effects on individuals who were inoculated with the J&J vaccine.

Although Johnson & Johnson strongly supports the sharing of information to the public and healthcare professionals, trading at Wall Street have since been seeing mixed reactions from investors as a result of the pause order.

Financial Markets Exhibiting Mixed Trading After the J&J Vaccine Pause

The Dow dipped, as Johnson & Johnson’s shares took a hit, falling by 2.7% single-month low due to the US FDA and Centres for Disease Control’s (CDC’s) joint announcement of the J&J vaccine pause. Nonetheless, trading of U.S. crude rose sharply, after the International Energy Agency raised its 2021 annual forecast for global oil demand.

Technology shares made gains at Nasdaq, particularly in relation to Coinbase’s direct listing debut. Listed as COIN, the largest cryptocurrency trader in the U.S. saw 31% gains from trading shares starting at Nasdaq’s current reference price of $250

Initially, the S&P 500 market exhibited little changes but trading improved after the federal health agencies’ announcement of the J&J vaccine pause, as investors started focusing on technology-related stocks.

Ask Trader Analysts Draw Attention to Their Review of Investment Brokers

While U.S. stock trade is currently mixed, readers who are still new to investing and currently looking for investment brokers, should read Ask Trader’s review of investment brokers offering their services online. Ask Trader’s tradeo review for one, was performed by a team of expert investment analysts to provide information on what the said broker is offering as investment options.

Tradeo specializes in brokering Contracts for Differences or CFDs, which although available for a range of assets like commodities, shares and foreign exchange does not involve actual ownership or physical delivery of such assets. CFDs merely allow traders to speculate on the future market movements of traded assets.

Based in Cyprus, and registered under the business name UR TRADE FIX Ltd and goes by the online name of Tradeo, take note that it is not FCA licensed. Primarily, this broker offers social trading services, a form of investing that mainly focuses on the trading behaviors of expert traders and peers. In doing so, Tradeo trading software supports the free-to-use Meta Trader 4 platform commonly used for foreign-exchange trading, but if compared to other foreign exchange brokers, it has fewer assets to offer.

Quote: " Finance is not merely about making money. It's about achieving our deep goals and protectingthe fruits of our labor. It's about stewardship and, therefore, about achieving the good society. "